24 May 2026
Recursion Pharmaceuticals (RXRX) Hits 52-Week Low; Is It In Oversold Territory?
With an upside potential of 99.1% and a relative strength index (RSI) of 33.8, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands out as one of the notable oversold play in the AI sector.
23 May 2026
CleanSpark (CLSK) PT Raised at Keefe Bruyette – Here’s Why
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward a year and Amazon’s new CEO Andy Jassy described...
22 May 2026
10 Cheap AI Stocks to Buy According to Analysts
On May 15, Alex Guiliano, CIO of Resonate Wealth Partners, joined BNN Bloomberg to suggest that valuations internationally look like an opportunity for investors to take advantage of.
09 May 2026
Jim Cramer on Palantir: “Great Margins, Terrific Revenue Growth”
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward a year and Amazon’s new CEO Andy Jassy described...
08 May 2026
8 Stocks on Jim Cramer’s Mad Money Recap: IBM, Corning, and AI Rally Strength
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward a year and Amazon’s new CEO Andy Jassy described...
08 May 2026
Jim Cramer’s Thoughts on 16 Stocks: Arista, Taiwan Semi, and Big Tech’s AI Spending
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward a year and Amazon’s new CEO Andy Jassy described...
